EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

C3d Complement Activation and Antibody Immunity in Convalescent COVID‐19: Insights From Adults and Children

Ratna Wijaya iD, Jordan Stoddart, Anurag Adhikari iD, Arunasingam Abayasingam iD, Adam W Bartlett iD, William Rawlinson iD, Michael M Mina iD, Jeffrey J Post iD, Bernard Hudson iD, Nicky Gilroy, Pam Konecny iD, Golo Ahlenstiel iD und 5 weitere

Journal of Immunology Research · 2026-01 · 2026 (1)

DOI: 10.1155/jimr/7429749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Immunology Research, online erschienen am 12.04.2026. Verfasst von Ratna Wijaya und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia, unsw.edu.au. Hauptthemen laut MEDLINE: COVID-19, Antibodies, Viral, Complement Activation, SARS-CoV-2. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Snow Medical Foundation, APEC-Australia Women in Research Fellowship, University of New South Wales.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, the complement pathway becomes activated, generating the stable split product C3d. Although C3d can modulate B cell responses through complement receptor 2 (CR2) in experimental systems, it remains unclear how circulating C3d relates to antibody responses after SARS‐CoV‐2 infection in humans. Here, we examined plasma C3d levels and their associations with SARS‐CoV‐2–specific antibody responses and clinical characteristics in convalescent adults and children. In adults, older age, male sex, and a history of severe COVID‐19 were independently associated with higher C3d levels. C3d concentrations positively correlated with receptor‐binding domain (RBD)‐specific antibody‐dependent cellular phagocytosis (ADCP), neutralizing antibody (nAb) titer, and anti‐spike IgM, IgG, IgG1, and IgG3 levels. In children, C3d levels were significantly lower than in adults and correlated with anti‐spike and anti‐RBD IgG titers. These findings demonstrate that systemic complement activation, reflected by circulating C3d, is positively associated with SARS‐CoV‐2 antibody responses in both age groups. As this cross‐sectional study cannot determine causality, further mechanistic and longitudinal studies are needed to define the role, if any, of C3d in shaping adaptive immunity to SARS‐CoV‐2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Antibodies, ViralComplement ActivationSARS-CoV-2Complement C3dHumansMaleAdultChildFemaleMiddle AgedAntibodies, NeutralizingChild, PreschoolAdolescentAgedImmunoglobulin GSpike Glycoprotein, CoronavirusYoung AdultConvalescenceCross-Sectional StudiesImmunoglobulin MAge Factors

Substanzen

Antibodies, ViralComplement C3dAntibodies, NeutralizingImmunoglobulin GSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Immunoglobulin M

Autor:innen und Institutionen

  • The Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia, unsw.edu.au.
  • School of Biomedical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia, unsw.edu.au.
  • Faculty of Medicine, University of Pelita Harapan, Tangerang, Indonesia.
  • Department of Infection and Immunology, Kathmandu Research Institute for Biological Sciences, Lalitpur, Nepal, kribs.org.np.
  • Sydney Children's Hospital Randwick, Sydney, New South Wales, Australia, schn.health.nsw.gov.au.
  • Serology and Virology Division, Department of Microbiology, NSW Health Pathology, Prince of Wales Hospital, Sydney, New South Wales, Australia, princeofwalesprivatehospital.com.au.

ORCID-Profile: Ratna Wijaya, Anurag Adhikari, Arunasingam Abayasingam, Adam W Bartlett, William Rawlinson, Michael M Mina, Jeffrey J Post, Bernard Hudson, Pam Konecny, Golo Ahlenstiel, Marianne Martinello, Andrew R Lloyd, Nicodemus Tedla, Rowena A Bull, Melanie R Walker

Förderung

  • Snow Medical Foundation
  • APEC-Australia Women in Research Fellowship
  • University of New South Wales
  • Council of Australasian University Librarians

Zitieren

APA

Wijaya, R., Stoddart, J., Adhikari, A., Abayasingam, A., Bartlett, A. W., Rawlinson, W., Mina, M. M., Post, J. J., Hudson, B., Gilroy, N., Konecny, P., Ahlenstiel, G., Martinello, M., Lloyd, A. R., Tedla, N., Bull, R. A., & Walker, M. R. (2026). C3d Complement Activation and Antibody Immunity in Convalescent COVID‐19: Insights From Adults and Children. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/7429749

Vancouver

Wijaya R, Stoddart J, Adhikari A, Abayasingam A, Bartlett AW, Rawlinson W, et al. C3d Complement Activation and Antibody Immunity in Convalescent COVID‐19: Insights From Adults and Children. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/7429749

BibTeX
@article{Wijaya2026,
  author = {Wijaya, Ratna and Stoddart, Jordan and Adhikari, Anurag and Abayasingam, Arunasingam and Bartlett, Adam W and Rawlinson, William and Mina, Michael M and Post, Jeffrey J and Hudson, Bernard and Gilroy, Nicky and Konecny, Pam and Ahlenstiel, Golo and Martinello, Marianne and Lloyd, Andrew R and Tedla, Nicodemus and Bull, Rowena A and Walker, Melanie R},
  title = {C3d Complement Activation and Antibody Immunity in Convalescent COVID‐19: Insights From Adults and Children},
  journal = {Journal of Immunology Research},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jimr/7429749}
}
Kostenlos starten →